SOPHiA GENETICS SA (SOPH) Operating cash flow 2019–2025
SOPHiA GENETICS SA (SOPH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$35.9MFY2025 · since FY2019: -$31.7M → -$35.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.9M | +19.4% |
| FY2024 | -$44.5M | +16.4% |
| FY2023 | -$53.2M | +24.1% |
| FY2022 | -$70.1M | -21.0% |
| FY2021 | -$57.9M | -82.6% |
| FY2020 | -$31.7M | -0.2% |
| FY2019 | -$31.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SOPH financial trends
SOPH RevenueSOPH Net incomeSOPH Net marginSOPH Gross profitSOPH Gross marginSOPH Operating incomeSOPH Operating marginSOPH Free cash flowSOPH Capital expendituresSOPH Return on equitySOPH Stock buybacksSOPH Dividends paidSOPH Total assetsSOPH Total liabilitiesSOPH Shareholders’ equitySOPH overview →